AGER and acute respiratory distress syndrome: Among the numerous biomarkers studied in the pathophysiology of ARDS, soluble receptor for advanced glycation end-products (sRAGE) has emerged as a potential key mediator, bridging the inflammatory and alveolar epithelial injury pathways characteristic of the syndrome.